Search Results

There are 66152 results for: content related to: MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

  1. Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

    Biotechnology and Bioengineering

    Volume 112, Issue 6, June 2015, Pages: 1102–1110, Jaina M. Patel, Vincent F. Vartabedian, Min-Chul Kim, Sara He, Sang-Moo Kang and Periasamy Selvaraj

    Version of Record online : 17 APR 2015, DOI: 10.1002/bit.25537

  2. XXVII International Congress of the International Academy of Pathology October 12-17, 2008, Athens, Greece POSTER PRESENTATIONS

    Histopathology

    Volume 53, Issue s1, October 2008, Pages: 1–432,

    Version of Record online : 24 SEP 2008, DOI: 10.1111/j.1365-2559.2008.03116.x

  3. You have free access to this content
    Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma

    Cancer

    Volume 101, Issue 2, 15 July 2004, Pages: 258–263, Ana M. Gonzalez-Angulo, Savitri Krishnamurthy, Yuko Yamamura, Kristine R. Broglio, Lajos Pusztai, Aman U. Buzdar, Gabriel N. Hortobagyi and Francisco J. Esteva

    Version of Record online : 14 JUN 2004, DOI: 10.1002/cncr.20348

  4. You have free access to this content
    Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

    Cancer

    Volume 113, Issue 6, 15 September 2008, Pages: 1294–1301, Suhail M. Ali, Walter P. Carney, Francisco J. Esteva, Monica Fornier, Lyndsay Harris, Wolfgang. J. Köstler, Jean-Pierre Lotz, Diana Luftner, Marie-France Pichon and Allan Lipton

    Version of Record online : 25 JUL 2008, DOI: 10.1002/cncr.23689

  5. You have full text access to this Open Access content
    Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer

    Cancer Science

    Volume 101, Issue 9, September 2010, Pages: 2026–2032, Rabindra N. Bhattacharjee, Alexander V. Timoshenko, Jing Cai and Peeyush K. Lala

    Version of Record online : 14 JUN 2010, DOI: 10.1111/j.1349-7006.2010.01647.x

  6. A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases

    Journal of Oral Pathology & Medicine

    Volume 46, Issue 3, March 2017, Pages: 167–174, Liang Xia, Yuhua Hu, Jiang Li, Ting Gu, Chunye Zhang, Lizhen Wang and Zhen Tian

    Version of Record online : 16 JUL 2016, DOI: 10.1111/jop.12477

  7. You have free access to this content
    Prognostic significance of HER-2 status in women with inflammatory breast cancer

    Cancer

    Volume 112, Issue 9, 1 May 2008, Pages: 1905–1911, Shaheenah Dawood, Kristine Broglio, Yun Gong, Wei-Tse Yang, Massimo Cristofanilli, Shu-Wan Kau, Funda Meric-Bernstam, Thomas A. Buchholz, Gabriel N Hortobagyi, Ana M. Gonzalez-Angulo and for the Inflammatory Breast Cancer Research Group

    Version of Record online : 25 FEB 2008, DOI: 10.1002/cncr.23350

  8. The Impact of HER-2 Status on Local Recurrence in Women with Stage I–II Breast Cancer Treated with Breast-Conserving Therapy

    The Breast Journal

    Volume 12, Issue 5, September 2006, Pages: 431–436, Eleanor E. R. Harris, Wei-Ting Hwang, Eric A. Lee, Keith A. Cengel, Michael D. Feldman, Angela DeMichele, Gary Kao and Lawrence J. Solin

    Version of Record online : 1 SEP 2006, DOI: 10.1111/j.1075-122X.2006.00297.x

  9. You have free access to this content
    Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder

    BJU International

    Volume 106, Issue 8, October 2010, Pages: 1216–1222, Christian Bolenz, Shahrokh F. Shariat, Pierre I. Karakiewicz, Raheela Ashfaq, Richard Ho, Arthur I. Sagalowsky and Yair Lotan

    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1464-410X.2009.09190.x

  10. You have free access to this content
    HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription–polymerase chain reaction, and fluorescence in situ hybridization

    International Journal of Gynecological Cancer

    Volume 18, Issue 1, January/February 2008, Pages: 14–21, F.E ODICINO, E BIGNOTTI, E ROSSI, B PASINETTI, R.A TASSI, C DONZELLI, M FALCHETTI, P FONTANA, P.G GRIGOLATO and S PECORELLI

    Version of Record online : 19 APR 2007, DOI: 10.1111/j.1525-1438.2007.00946.x

  11. You have free access to this content
    HER-2 profiling and targeting in prostate carcinoma

    Cancer

    Volume 94, Issue 4, 15 February 2002, Pages: 980–986, Michael J. Morris, Victor E. Reuter, W. Kevin Kelly, Susan F. Slovin, Kate Kenneson, David Verbel, Iman Osman and Howard I. Scher

    Version of Record online : 20 FEB 2002, DOI: 10.1002/cncr.10339

  12. You have full text access to this OnlineOpen article
    Analysis of different HER-2 mutations in breast cancer progression and drug resistance

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 12, December 2015, Pages: 2691–2701, Zijia Sun, Yaqin Shi, Yan Shen, Lulu Cao, Wenwen Zhang and Xiaoxiang Guan

    Version of Record online : 25 AUG 2015, DOI: 10.1111/jcmm.12662

  13. Genetic alterations in endometrial carcinomas

    International Journal of Gynecological Cancer

    Volume 8, Issue 5, September 1998, Pages: 415–422, Van Nostrand, Johnson, Monk, Wilczynski, Chapman, Brightman, Schell, Berman, Manetta, Disaia and Fan

    Version of Record online : 5 JAN 2002, DOI: 10.1046/j.1525-1438.1998.09812.x

  14. You have free access to this content
    Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy

    International Journal of Cancer

    Volume 99, Issue 1, 1 May 2002, Pages: 100–105, Alexander Fosså, Wolfgang Lilleby, Sophie D. Fosså, Gustav Gaudernack, Goran Torlakovic and Aasmund Berner

    Version of Record online : 25 FEB 2002, DOI: 10.1002/ijc.10286

  15. You have free access to this content
    Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

    Cancer

    Volume 104, Issue 10, 15 November 2005, Pages: 2149–2155, Lee M. Krug, Vincent A. Miller, Jyoti Patel, John Crapanzano, Christopher G. Azzoli, Jorge Gomez, Mark G. Kris, Robert T. Heelan, Barbara Pizzo, Leslie Tyson, Christine Sheehan, Jeffrey S. Ross and Ennapadam Venkatraman

    Version of Record online : 5 OCT 2005, DOI: 10.1002/cncr.21428

  16. ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells

    The Prostate

    Volume 72, Issue 7, 15 May 2012, Pages: 777–788, Cécile Le Page, Ismaël Hervé Koumakpayi, Benjamin Péant, Nathalie Delvoye, Fred Saad and Anne-Marie Mes-Masson

    Version of Record online : 19 SEP 2011, DOI: 10.1002/pros.21483

  17. You have free access to this content
    HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

    International Journal of Cancer

    Volume 122, Issue 5, 1 March 2008, Pages: 999–1004, Alfredo Santinelli, Eleonora Pisa, Daniela Stramazzotti and Guidalberto Fabris

    Version of Record online : 31 OCT 2007, DOI: 10.1002/ijc.23051

  18. You have free access to this content
    Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma

    Cancer

    Volume 98, Issue 1, 1 July 2003, Pages: 66–73, Estrid V. S. Høgdall, Lise Christensen, Susanne K. Kjaer, Jan Blaakaer, Johannes E. Bock, Eva Glud, Bent Nørgaard-Pedersen and Claus K. Høgdall

    Version of Record online : 22 MAY 2003, DOI: 10.1002/cncr.11476

  19. Significant prognostic factor of immunohistochemical HER-2 expression using initial prostate biopsy specimens with M1b prostate cancer

    The Prostate

    Volume 71, Issue 4, 1 March 2011, Pages: 385–393, Motoi Tobiume, Yoshiaki Yamada, Kogenta Nakamura, Shigeyuki Aoki, Kenji Zennami, Yoshiharu Kato, Genya Nishikawa, Toyoharu Yokoi and Nobuaki Honda

    Version of Record online : 1 SEP 2010, DOI: 10.1002/pros.21252

  20. You have free access to this content
    Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer

    Cytometry Part A

    Volume 71A, Issue 5, May 2007, Pages: 273–285, Aparna S. Joshi, Girish M. Sharangpani, Kyle Porter, Sedigheh Keyhani, Carl Morrison, Amitabha S. Basu, Gauri A. Gholap, Abhi S. Gholap and Sanford H. Barsky

    Version of Record online : 23 FEB 2007, DOI: 10.1002/cyto.a.20374